Skip to main content
Erschienen in: Investigational New Drugs 3/2020

03.06.2019 | PRECLINICAL STUDIES

Effects of chemotherapy on placental development and function using in vitro culture of human primary cytotrophoblasts

verfasst von: Christophe Louis Depoix, Arthur Colson, Mina Mhallem-Gziri, Corinne Hubinont, Frederic Debieve

Erschienen in: Investigational New Drugs | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Summary

Introduction Cancers during pregnancy can be treated with chemotherapy after the first trimester but the treatment is associated with smaller placentas and an increased risk of stillbirth, fetal growth retardation and preterm delivery. We decided to assess the effect of several chemotherapeutic agents on placental development by using in vitro culture of human term cytotrophoblasts. Methods Cytotrophoblasts isolated from term placentas were cultured for 48 h and treated for 24 h with epirubicin, docetaxel, vinblastine, methotrexate, tamoxifen, 4-hydroxytamoxifen, and endoxifen. First, cell viability was assessed. Then, the effect of the treatment on trophoblast differentiation and placental angiogenesis was assessed by quantifying hCG and PlGF mRNA and protein expression. Finally, the expression of two efflux transporters, BCRP and MDR1 was investigated. Results Epirubicin only strongly decreased cell viability. Epirubicin, docetaxel, and vinblastine inhibited HCGB and PlGF expression while methotrexate, tamoxifen and its two metabolites increased it. BCRP was essentially expressed in syncytiotrophoblasts and MDR1 in undifferentiated cytotrophoblasts. Their expression was not affected by the drugs but vinblastine increased BCRP mRNA expression by 2.8-fold. Discussion The most commonly used chemotherapeutic drugs are well supported in vitro by syncytiotrophoblasts, except for epirubicin, which was very cytotoxic. Chemotherapy perturbed the expression of genes normally upregulated during placental differentiation and angiogenesis but not the expression of the drug transporters. Further studies looking at the effect of combination therapy and the transporter capacities to reject the drugs will be needed to better define the effects of chemotherapy on placental development and function.
Literatur
1.
Zurück zum Zitat Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287CrossRef Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7(4):279–287CrossRef
2.
Zurück zum Zitat Ebert U, Loffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74(2):207–220CrossRef Ebert U, Loffler H, Kirch W (1997) Cytotoxic therapy and pregnancy. Pharmacol Ther 74(2):207–220CrossRef
7.
Zurück zum Zitat Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA (1999) The effects of methotrexate on pregnancy, fertility and lactation. QJM 92(10):551–563CrossRef Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA (1999) The effects of methotrexate on pregnancy, fertility and lactation. QJM 92(10):551–563CrossRef
8.
Zurück zum Zitat Ostensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27(8):1872–1875PubMed Ostensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27(8):1872–1875PubMed
9.
Zurück zum Zitat Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Descotes J, French Network of Regional Pharmacovigilance C (2004) Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol 31(12):2360–2365PubMed Lewden B, Vial T, Elefant E, Nelva A, Carlier P, Descotes J, French Network of Regional Pharmacovigilance C (2004) Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study. J Rheumatol 31(12):2360–2365PubMed
10.
Zurück zum Zitat Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H (2002) The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol 55(7):514–519CrossRef Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H (2002) The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol 55(7):514–519CrossRef
13.
Zurück zum Zitat Debieve F, Pampfer S, Thomas K (2000) Inhibin and activin production and subunit expression in human placental cells cultured in vitro. Mol Hum Reprod 6(8):743–749CrossRef Debieve F, Pampfer S, Thomas K (2000) Inhibin and activin production and subunit expression in human placental cells cultured in vitro. Mol Hum Reprod 6(8):743–749CrossRef
14.
Zurück zum Zitat Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675CrossRef Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675CrossRef
15.
Zurück zum Zitat Kaklamani VG, Gradishar WJ (2003) Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? Clin Breast Cancer 4(Suppl 1):S26–S33CrossRef Kaklamani VG, Gradishar WJ (2003) Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? Clin Breast Cancer 4(Suppl 1):S26–S33CrossRef
17.
Zurück zum Zitat Ho HH, Douglas GC, Qiu QF, Thirkill TL, Overstreet JW, Lasley BL (1997) The relationship between trophoblast differentiation and the production of bioactive hCG. Early Pregnancy 3(4):291–300PubMed Ho HH, Douglas GC, Qiu QF, Thirkill TL, Overstreet JW, Lasley BL (1997) The relationship between trophoblast differentiation and the production of bioactive hCG. Early Pregnancy 3(4):291–300PubMed
18.
Zurück zum Zitat Ribatti D (2008) The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 11:215–221CrossRef Ribatti D (2008) The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 11:215–221CrossRef
21.
Zurück zum Zitat Fabian C, Tilzer L, Sternson L (1981) Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer. Biopharm Drug Dispos 2(4):381–390CrossRef Fabian C, Tilzer L, Sternson L (1981) Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer. Biopharm Drug Dispos 2(4):381–390CrossRef
22.
Zurück zum Zitat Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54(1):138–153CrossRef Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54(1):138–153CrossRef
24.
Zurück zum Zitat Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M (2001) Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 61(4):1652–1658PubMed Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M (2001) Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 61(4):1652–1658PubMed
25.
Zurück zum Zitat Sharma SC, Purohit P, Rao AJ (1993) Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta. J Mol Endocrinol 11(1):91–101CrossRef Sharma SC, Purohit P, Rao AJ (1993) Role of oestradiol-17 beta in the regulation of synthesis and secretion of human chorionic gonadotrophin by first trimester human placenta. J Mol Endocrinol 11(1):91–101CrossRef
27.
Zurück zum Zitat Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61(8):3458–3464PubMed Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61(8):3458–3464PubMed
Metadaten
Titel
Effects of chemotherapy on placental development and function using in vitro culture of human primary cytotrophoblasts
verfasst von
Christophe Louis Depoix
Arthur Colson
Mina Mhallem-Gziri
Corinne Hubinont
Frederic Debieve
Publikationsdatum
03.06.2019
Verlag
Springer US
Erschienen in
Investigational New Drugs / Ausgabe 3/2020
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI
https://doi.org/10.1007/s10637-019-00800-9

Weitere Artikel der Ausgabe 3/2020

Investigational New Drugs 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.